A synthesis strategy to tailor the acid sites location in ferrierite crystals has been developed. The zeolite catalysts were synthesised in fluoride medium using different combinations of organic structure directing agents (SDAs) in the absence of inorganic cations. Therefore, the negative charge associated to the incorporation of aluminium to the framework was compensated exclusively by the positive charge of the organic SDAs. In this way, Al sitting in the zeolite framework was driven by the specific location of the different SDA molecules within the zeolite void volume. Following this synthesis strategy, it has been found that the distribution of strongly acidic hydroxyl 1 groups in the proton form of the zeolites obtained after removal of the organic templates was dependent on the combination of organic molecules used as SDAs. Moreover, the catalytic activity of the zeolites in m-xylene and 1-butene isomerization increased as the relative population of strong Brönsted acid groups in sterically constrained sites inside the ferrierite cavity decreased.
The skeletal isomerization of n-butenes to isobutene has been carried out over ferrierite catalysts (Si/Al * 15) containing different acid sites distribution and different amount of defects. The zeolite crystals were synthesized under hydrothermal conditions in fluoride medium in the absence of alkaline cations by using suitable combinations of structure directing agents. Template-driven low density of acid sites in 10-membered-ring channels enhances the isobutene selectivity and decreases catalyst deactivation. The presence of high amount of silanol groups and Lewis acid sites increases the yields of by-products and catalysts decay.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.